Navigation Links
2013 Wiley Prize awarded for circadian rhythm research
Date:4/8/2013

Hoboken, N.J. April 5, 2013 - Deborah E. Wiley, Chair of The Wiley Foundation, John Wiley & Sons, Inc. (NYSE: JWa & JWb) today awarded the 2013 Wiley Prize in Biomedical Sciences to Dr. Michael Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University.

The three researchers received their award at Rockefeller University in New York City, where they were honored at a luncheon and then presented a lecture on their discovery of the molecular mechanisms governing circadian rhythms.

"I would like to congratulate Drs. Young, Rosbash and Hall for this well-deserved honor," said Wiley. "Their groundbreaking research on circadian rhythms has the potential to lead to more discoveries that could help many people who are suffering from very common maladies and disorders."

"I am extremely pleased to be able to recognize this outstanding achievement in the area of biomedical research."

Studies of the molecular basis for circadian rhythmicity began more than thirty years ago in the lab of Dr. Young at Rockefeller University and Drs. Hall and Rosbash at Brandeis. Over the past three decades, the work of the three men focused on the fruitfly Drosophila melanogaster, with their research showing that the fly's circadian clocks are formed through the actions of a small group of genes.

These discoveries also apply to humans and other mammals, and could ultimately lead to the development of drugs to treat sleep disorders and jet lag, plus conditions associated with employees who work non-traditional shifts.

There is also evidence that the effectiveness of many drugs (including chemotherapeutics), our ability to fight infection, our ability to repair damaged tissues, and the incidence of certain forms of cancer depend on the proper working of circadian clocks.

This year's three winners have authored a number of articles published on Wiley Online Library. Free access will be offered to these articles for the remainder of 2013. They can be accessed at http://olabout.wiley.com/WileyCDA/Section/id-816285.html?dmmsmid=72394&dmmspid=18999591&dmmsuid=1922750.

Among the many distinguished past recipients of the Wiley Prize in Biomedical Sciences, five have also been awarded the Nobel Prize for Physiology or Medicine. Dr. Elizabeth Blackburn and Dr. Carol Greider, recipients of the Wiley Prize in Biomedical Sciences in 2006, received the 2009 Nobel Prize in Physiology or Medicine for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase. Dr. Andrew Z. Fire and Dr. Craig C. Mello, co-recipients of the Wiley Prize in 2003, received the 2006 Nobel Prize for Physiology or Medicine for their discovery of RNA interferencegene silencing by double-stranded RNA. Dr. H. Robert Horvitz, a co-recipient of the first Wiley Prize in 2002, shared the 2002 Nobel Prize for Physiology or Medicine for his respective work on how genes regulate organ development and cell death.

The Wiley Prize in Biomedical Sciences recognizes specific contribution or series of contributions that demonstrate significant leadership in the development of research concepts or their clinical application. Particular emphasis is placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.

The Wiley Foundation and the Wiley Prize in Biomedical Sciences were established in 2001.


'/>"/>

Contact: Peter Peretzman
sciencenewsroom@wiley.com
201-268-4324
Wiley
Source:Eurekalert

Related medicine news :

1. Wiley launches new open access journal: Immunity, Inflammation and Disease
2. New Wiley Open Access title launches: Journal of Medical Radiation Sciences
3. Twelfth annual Wiley Prize in Biomedical Sciences awarded
4. Molecular Genetics & Genomic Medicine: New open access journal launched by Wiley
5. A*STAR scientist Alex Matter awarded prestigious Szent-Györgyi Prize for progress in cancer
6. Student Wins Grand Prize Using ATP Rapid Hygiene Monitoring System from Kaivac
7. Surgery is superior to radiotherapy in men with localized PCa, says prize-winning Swedish study
8. Study of dragonfly prey detection at MBL wins PNAS Cozzarelli Prize
9. Geneticist Mary-Claire King receives the 2013 Paul Ehrlich Prize
10. Brain researcher James Poulet receives the 2013 Paul Ehrlich Prize for Young Researchers
11. Peter Piot awarded Hideyo Noguchi Africa Prize for Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: